RB-mediated tumor suppression of a lung cancer cell line is abrogated by an extract enriched in extracellular matrix
Related Experiment Video
Updated: Aug 8, 2026
Tissue Engineering of Tumor Stromal Microenvironment with Application to Cancer Cell Invasion
Published on: March 18, 2014
R A Kratzke1, E Shimizu, J Geradts
1NCI-Navy Medical Oncology Branch, National Cancer Institute, Bethesda, Maryland 20889.
Abstract:
To examine whether the expression of retinoblastoma (RB) protein could mediate tumor suppression in a lung carcinoma cell line carrying multiple genetic defects, we transfected the Rb gene into a non-small cell lung cancer cell line with absent RB protein. We observed that the stable expression of a functional RB product was associated with a decreased efficiency of soft agar cloning and partial suppression of tumorigenicity in nude mice. The suppression of tumorigenicity was marked when 10(6) cells were injected into the flanks of nude mice but was less prominent when 10(7) cells were injected. RB-mediated tumor suppression, however, was consistently blocked by preincubation of the transfected cells with an extract enriched with an extracellular matrix (Matrigel). Analysis of tumors harvested from nude mice showed that they continued to express detectable levels of human RB protein which retained functional E1A binding activity and nuclear localization. RB-mediated inhibition of soft agar cloning was also blocked in a dose-dependent manner by the addition of Matrigel. These observations demonstrate that the expression of wild-type RB may suppress certain parameters of tumorigenicity in lung carcinoma cells that contain multiple genetic alterations. In addition, the reversal of tumor suppression by an extract enriched in basement membrane components may offer clues for further investigations into the mechanism of RB-mediated tumor suppression.
Insights
Retinoblastoma (RB) protein expression suppressed lung cancer cell growth and tumor formation in mice. However, extracellular matrix components blocked this tumor suppressive effect, suggesting a novel mechanism.
Area of Science:
- Oncology
- Molecular Biology
- Cell Biology
Background:
- The retinoblastoma (RB) protein is a critical tumor suppressor.
- Lung cancer, particularly non-small cell lung cancer (NSCLC), often involves genetic alterations affecting tumor suppressor pathways.
- The role of RB protein in mediating tumor suppression in genetically compromised cancer cells requires further elucidation.
Purpose of the Study:
- To investigate if retinoblastoma (RB) protein expression can mediate tumor suppression in a lung carcinoma cell line with multiple genetic defects.
- To explore the influence of extracellular matrix components on RB-mediated tumor suppression.
Main Methods:
- Transfection of the Rb gene into an RB-deficient non-small cell lung cancer (NSCLC) cell line.
- Assessment of soft agar cloning efficiency and tumorigenicity in nude mice.
- Evaluation of RB protein expression, E1A binding activity, and nuclear localization in tumors.
- Investigation of the effect of Matrigel (extracellular matrix extract) on RB-mediated suppression.
Main Results:
- Stable expression of functional RB protein decreased soft agar cloning efficiency and partially suppressed tumorigenicity in nude mice.
- Tumor suppression was more pronounced at lower cell doses (10^6 cells) compared to higher doses (10^7 cells).
- RB-mediated tumor suppression and inhibition of soft agar cloning were blocked by Matrigel in a dose-dependent manner.
Conclusions:
- Wild-type RB protein expression can suppress certain tumorigenic parameters in lung carcinoma cells with multiple genetic alterations.
- Extracellular matrix components, such as those in Matrigel, can reverse RB-mediated tumor suppression.
- These findings suggest a potential role for the tumor microenvironment in modulating RB's tumor suppressive functions and offer avenues for future mechanistic studies.
